66
D. Murtinho et al. / Tetrahedron: Asymmetry 21 (2010) 62–68
4.2.1.3. N-((1S,3R)-3-Amino-2,2,3-trimethylcyclopentyl)benz-
amide 4. The product was purified by silica gel column chro-
7.5 mL of HCl 2 M were added and the solution was evaporated un-
der reduced pressure. The residue was dissolved in water and
NaOH 15% was added to basic pH. The resulting mixture was ex-
tracted several times with dichloromethane. The joint organic
phases were dried over anhydrous Na2SO4. After evaporating the
solvent, the product was purified as described below.
matography (diethyl ether/triethylamine 80:2) to afford a low
melting solid (90%).
½
a 2D5
ꢀ
¼ þ80 (c 1.5, CH2Cl2). 1H NMR
(400 MHz, CDCl3) d: 0.95 (s, 3H), 0.96 (s, 3H), 1.16 (s, 3H), 1.54–
1.65 (m, 2H), 1.82–1.89 (m, 1H), 2.25–2.34 (m, 1H), 4.36 (approx.
t, 1H, J 8.4), 7.38–7.45 (m, 3H), 7.78–7.80 (m, 2H), 8.75 (d, 1H, J
7.8).
4.2.3.1. N-((1S,3R)-3-(Dimethylamino)-2,2,3-trimethylcyclopen-
tyl)-4-methylbenzene-sulfonamide 8.
The product was
white solid was obtained
¼ þ20 (c 1.0, CH2Cl2). IR (KBr,
4.2.1.4. Benzyl (1S,3R)-3-amino-2,2,3-trimethylcyclopentylcar-
recrystallized in CH2Cl2/hexane. A
bamate 5.
The product was purified by silica gel column chro-
(44%). Mp 191 °C (sublimes); ½a D25
ꢀ
matography (dichloromethane/methanol 95:5) to afford an oil
(81%). The product was used directly in the next step. 1H NMR
(400 MHz, CDCl3) d: 0.88 (s, 6H), 1.09 (s, 3H), 1.49–1.60 (m, 2H),
1.66–1.78 (m, 1H), 2.15–2.25 (m, 1H), 3.82–3.87 (m, 1H), 5.06 (d,
1H, J 12.6), 5.10 (d, 1H, J 12.6), 6.57 (d, 1H, J 9.2), 7.26–7.35 (m, 5H).
cmꢁ1): 3292, 3251, 2969, 2820, 2777, 1438, 1345, 1323, 1161,
1077, 914, 817, 667, 566, 550. 1H NMR (300 MHz, CDCl3) d: 0.84
(s, 3H), 0.89 (s, 3H), 0.95 (s, 3H), 1.38–1.47 (m, 1H), 1.61–1.80
(m, 3H), 2.16 (s, 6H), 2.42 (s, 3H), 3.35–3.38 (m, 1H), 4.60 (d, 1H,
J 10.1), 7.29 (d, 2H, J 8.2), 7.75 (d, 2H, J 8.2). 13C NMR (100 MHz,
CDCl3) d: 11.21, 17.18, 21.54, 22.43, 27.55, 36.53, 40.14, 47.25,
62.46, 66.18, 126.99, 129.63, 138.41, 143.17. GC–MS (EI) m/z:
324 (M+, 2%), 169 (6), 154 (100), 98 (21), 86 (13), 69 (7), 56 (6).
Anal. Calcd for C17H28N2O2S: C, 62.93; H, 8.70; N, 8.63; S, 9.88.
Found: C, 62.76; H, 9.08; N, 8.37; S, 10.38.
4.2.2. General procedure for the synthesis of compounds 6 and
7
To a stirred solution of diamine 1 (0.71 g, 5 mmol) in dry dichlo-
romethane (50 mL) and triethylamine (1.53 mL, 11 mmol) was
added, at 0 °C in an inert atmosphere, a solution of the sulfonyl
chloride (11 mmol) in dry dichloromethane (20 mL). The reaction
mixture was stirred overnight at room temperature. The reaction
mixture was extracted with HCl 2 M and water. The organic phase
was dried over anhydrous Na2SO4. After evaporating the solvent,
the product was purified as described below.
4.2.3.2. N-((1S,3R)-3-(Dimethylamino)-2,2,3-trimethylcyclopen-
tyl)benzamide 9.
The product was recrystallized in CH2Cl2/
hexane to give a white solid (96%). Mp 141–143 °C (lit. 135–
137 °C); ½a 2D5
ꢀ
¼ þ25 (c 1.0, CH2Cl2); [lit. +30 (c 0.6, CHCl3)].23 1H
NMR (300 MHz, CDCl3) d: 1.02 (s, 3H), 1.03 (s, 3H), 1.06 (s, 3H),
1.40–1.50 (m, 1H), 1.60–1.69 (m, 1H), 1.91–1.97 (m, 1H), 2.10–
2.23 (m, 1H), 2.25 (s, 6H), 4.47 (q, 1H, J 9.4), 6.48 (d, 1H, J 9.4),
7.41–7.50 (m, 3H), 7.75–7.78 (m, 2H).
4.2.2.1. N,N0-((1R,3S)-1,2,2-Trimethylcyclopentane-1,3-diyl)-
bis(4-methylbenzene-sulfonamide) 6.
The product was
recrystallized in CHCl3/hexane to give a white solid (35%). Mp
205–206 °C; ½a 2D5
ꢀ
¼ þ30 (c 0.5, CHCl3). IR (KBr, cmꢁ1): 3585,
4.2.3.3. Benzyl (1S,3R)-3-(dimethylamino)-2,2,3-trimethylcycl-
3501, 3246, 2973, 2590, 1455, 1318, 1303, 1160, 1134, 1094,
1079, 816, 708. 1H NMR (300 MHz, CDCl3) d: 0.79 (s, 3H), 0.88 (s,
3H), 0.92–1.04 (m, 1H), 1.09 (s, 3H), 1.47–1.57 (m, 1H), 1.64–1.77
(m, 1H), 2.05–2.15 (m, 1H), 2.41 (s, 3H), 2.43 (s, 3H), 3.25–3.34
(m, 1H), 4.49 (s, 1H), 5.50 (d, 1H, J 10.0), 7.25–7.31 (m, 4H), 7.66
(d, 2H, J 8.3), 7.74 (d, 2H, J 8.3). 13C NMR (75.5 MHz, CDCl3) d:
17.61, 21.47, 21.69, 23.06, 28.45, 33.04, 48.42, 60.81, 68.39,
76.68, 126.98, 127.01, 129.62, 129.71, 138.22, 140.06, 143.26,
143.30. LC–MS (ES+) m/z: 451 [(M+1)+, 100%], 434 (37), 375 (38),
345 (27). Anal. Calcd for C22H30N2S2O4ꢂ1/2H2O: C, 57.49; H, 6.80;
N, 6.09; S, 13.95. Found: C, 57.12; H, 6.54; N, 6.41; S, 13.40.
opentylcarbamate 10.
The product was purified by silica
gel column chromatography (diethyl ether/triethylamine 80:2) to
afford the product as an oil (55%). ½a D25
¼ þ20 (c 1.0, CH2Cl2). IR
ꢀ
(KBr, cmꢁ1): 2966, 1702, 1535, 1396, 1243, 1221, 1049, 1028,
737, 697. 1H NMR (400 MHz, CDCl3) d: 0.89 (s, 3H), 0.96 (s, 3H),
1.02 (s, 3H) 1.27–1.36 (m, 1H), 1.52–1.59 (m, 1H), 1.80–1.88 (m,
1H), 1.90–2.10 (m, 1H), 2.20 (s, 6H), 3.96 (q, 1H, J 9.6), 4.75 (d,
1H, J 9.6), 5.06 (d, 1H, J 12.4), 5.12 (d, 1H, J 12.4), 7.33–7.37 (m,
5H). 13C NMR (100 MHz, CDCl3) d: 11.14, 14.14, 17.06, 22.66,
26.85, 36.65, 40.11, 47.14, 59.59, 66.52, 66.70, 128.13, 128.16,
128.54, 136.58, 156.35. GC–MS (EI) m/z: 304 (M+, 8%), 289 (3),
154 (87), 98 (100), 91 (37), 85 (43), 56 (10). HRMS (EI+, [M]+) m/
z: calcd for (C18H28N2O2) 304.2151; found 304.2137.
4.2.2.2. N,N0-((1R,3S)-1,2,2-Trimethylcyclopentan-1,3-diyl)-bis-
((1S)-(7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methane-
sulfonamide 7.
hexane to give
The product was recrystallized in CH2Cl2/
white solid (48%). Mp 184 °C (sublimes);
4.2.4. General procedure for the synthesis of compounds 11–12
A mixture of compound 4 (2.46 g, 10 mmol), K2CO3 (5.5 g,
40 mmol) and ethyl iodide (3.23 mL, 40 mmol for compound 11
and 8.12 mL, 100 mmol for compound 12), in dry ethanol (60 mL)
was refluxed for 24 h. The resulting solution was cooled to room
temperature and the solvent evaporated under reduced pressure.
Water and dichloromethane were added and the aqueous phase
was extracted several times with dichloromethane. The combined
organic phases were dried over anhydrous Na2SO4. The products
were purified as described below.
a
½
a 2D5
ꢀ
¼ þ40 (c 1.0, CH2Cl2). IR (KBr, cmꢁ1): 3244, 2968, 1732,
1456, 1418, 1395, 1328, 1146, 1080, 1052, 1017, 594, 577. 1H
NMR (300 MHz, CDCl3) d: 0.90 (s, 3H), 0.92 (s, 3H), 1.00 (s, 3H),
1.02 (s, 3H), 1.04 (s, 3H), 1,07 (s, 3H), 1.43 (s, 3H) 1.90–2.18 (m,
12H), 2.29–2.47 (m, 6H), 2.92 (d, 1H, J 6.2), 2.97 (d, 1H, J 6.2),
3.44 (d, 1H, J 15.0), 3.55 (d, 1H, J 15.0), 3.61–3.70 (m, 1H), 5.35
(d, 1H, J 9.2), 5.71 (s, 1H). 13C NMR (100 MHz, CDCl3) d: 17.77,
19.48, 19.73, 19.93, 19.97, 22.18, 23.12, 26.21, 26.33, 26.97,
27.02, 29.72, 34.27, 42.70, 42.78, 42.84, 42.94, 48.42, 48.66,
49.03, 51.38, 53.93, 59.10, 59.37, 61.11, 67.33, 216.26, 218.07. Anal.
Calcd for C28H46N2O6S2: C, 58.92; H, 8.12; N, 4.91. Found: C, 58.75;
H, 8.27; N, 4.72.
4.2.4.1. N-((1S,3R)-3-(Ethylamino)-2,2,3-trimethylcyclopen-
tyl)benzamide 11.
The product was purified by silica gel col-
umn chromatography using diethyl ether as eluent to give a white
solid (67%). Mp 128–129 °C; ½a D25
¼ þ60 (c 1.0, CH2Cl2). IR (KBr,
ꢀ
4.2.3. General procedure for the synthesis of compounds 8–10
To 2 mL (50 mmol) of 98% formic acid, cooled in an ice bath, was
slowly added compound 2, 4 or 5 (10 mmol). To the resulting mix-
ture were added 2.5 mL (30 mmol) of a formaldehyde solution
(34%) and was stirred at reflux overnight. The solution was cooled,
cmꢁ1): 3293, 2960, 2868, 1650, 1579, 1520, 1483, 1351, 703. 1H
NMR (400 MHz, CDCl3) d: 0.95 (s, 3H), 0.99 (s, 3H), 1.08 (s, 3H),
1.16 (t, 3H, J 7.1), 1.51–1.60 (m, 2H), 1.68–1.71 (m, 1H), 1.94–
2.06 (m, 1H), 2.27–2.34 (m, 1H), 2.56–2.61 (m, 1H), 2.65–2.71
(m, 1H), 4.30 (approx. t, 1H, J 8.4), 7.39–7.51 (m, 3H), 7.78–7.80